BioGaia AB (publ) (BIOG-B)
Stockholm Exchange · Sweden · prices in SEK · close of 22 Oct 2026
Key indicators
| Last close | SEK 129.30 |
|---|---|
| 52-week range | 96.20 – 136.30 |
| Return, 1 month / 3 months | +18.5% / +10.2% |
| Return, 1 year / 3 years | +26.4% / +52.9% |
| Trend | Uptrend |
| RSI (14) | 80 |
| Volatility (1 year) | 28.2% |
| Worst drawdown (1 year) | -20.5% |
| Average daily value traded | 19.18M SEK |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
BioGaia AB is a Swedish company that develops and markets probiotic products built around beneficial bacteria, chiefly strains of Lactobacillus reuteri. Its range includes drops, tablets, chewable products and sachets aimed at digestive and oral health, with uses such as infant colic and general gut comfort. The company sells these products to consumers through pharmacies, retailers and healthcare channels, working with distribution partners and subsidiaries in many countries, and it is based in Stockholm, Sweden.
BioGaia AB (publ) trades under the code BIOG-B on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BioGaia AB (publ) (BIOG-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 129.30 on 22 October 2026.
Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 78 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.4% and over the last three months it rose 10.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.6% | ||
| From 52-week high | -4.2% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.2% | ||
| 6-month return | 9.8% | ||
| 12-month return, skipping the last month | 6.7% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.5% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 19.18M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +5.3% |
|---|---|
| 1 month | +18.5% |
| 3 months | +10.2% |
| 6 months | +9.8% |
| 1 year | +26.4% |
| 3 years | +52.9% |
| 5 years | +55.2% |
Signals
| 50-day / 200-day average | 114.86 / 114.79 |
|---|---|
| Golden / death cross (60 days) | Golden, 0 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.11 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2026 | SEK 4.0000 |
| 8 May 2025 | SEK 6.9000 |
| 8 May 2024 | SEK 6.9000 |
| 8 May 2023 | SEK 2.9000 |
| 9 May 2022 | SEK 14.9200 |
| 7 May 2021 | SEK 3.4100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.